IALSN presents "New Antimicrobial Agents for Multi-Drug Resistant Pathogens" by Michael N. Dudley, PharmD, FIDSA
December 12, 2014
IALSN presents:“Biologic Therapies As A Critical Source Of Innovation: The Lilly Biotechnology Strategy”
May 15, 2015
Thomas F. Bumol, Ph.D.
Senior VP – Biotechnology and Immunology Research, Lilly Research Laboratories
Thomas F. Bumol, Ph.D., is the Senior Vice President of the Biotechnology and Autoimmunity Research components at Lilly Research Laboratories, Indianapolis, Indiana and the Site Head of Lilly’s Biotechnology Center of San Diego, which includes the Applied Molecular Evolution component of Lilly Research Laboratories and early clinical development for autoimmune assets fro LRL. He is also the co-chair of the company’s Bioproduct Strategy Group, co-chair of the Research and Development Subcommittee for Immunology and a member of the company’s Portfolio Management Team & Research Management Team.